Related references
Note: Only part of the references are listed.A HER2 target antibody drug conjugate combined with anti-PD-(L)1 treatment eliminates hHER2+tumors in hPD-1 transgenic mouse model and contributes immune memory formation
Lei Huang et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Novel evidence for m6A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer
Tadanobu Shimura et al.
BRITISH JOURNAL OF CANCER (2022)
miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancer
Cheng Zhang et al.
GASTRIC CANCER (2022)
The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer
Xuefei Jiang et al.
FRONTIERS IN GENETICS (2022)
The Prognostic Value of the Developmental Gene FZD6 in Young Saudi Breast Cancer Patients: A Biomarkers Discovery and Cancer Inducers OncoScreen Approach
Mourad Assidi et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer
Gaya Spolverato et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?
Laetitia Lesire et al.
CELLS (2022)
Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC)
Xing Zeng et al.
FRONTIERS IN ONCOLOGY (2022)
DNMBP-AS1 Regulates NHLRC3 Expression by Sponging miR-93-5p/17-5p to Inhibit Colon Cancer Progression
Lijie Yang et al.
FRONTIERS IN ONCOLOGY (2022)
Functional role of the Frizzled linker domain in the Wnt signaling pathway
Seung-Bum Ko et al.
COMMUNICATIONS BIOLOGY (2022)
RAB19 Directs Cortical Remodeling and Membrane Growth for Primary Ciliogenesis
Cayla E. Jewett et al.
DEVELOPMENTAL CELL (2021)
Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma
Yi Jin et al.
FRONTIERS IN IMMUNOLOGY (2021)
MicroRNA-935 Directly Targets FZD6 to Inhibit the Proliferation of Human Glioblastoma and Correlate to Glioma Malignancy and Prognosis
Dainan Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
Delivery technologies to engineer natural killer cells for cancer immunotherapy
Rakan El-Mayta et al.
CANCER GENE THERAPY (2021)
Identification of an m6A Regulators-Mediated Prognosis Signature For Survival Prediction and Its Relevance to Immune Infiltration in Melanoma
Liuxing Wu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
β-Lactoglobulin and Glycodelin: Two Sides of the Same Coin?
Lindsay Sawyer
FRONTIERS IN PHYSIOLOGY (2021)
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
Ella S. Atsavapranee et al.
EBIOMEDICINE (2021)
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Philipp Sievers et al.
ACTA NEUROPATHOLOGICA (2021)
CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability
Yu Zhang et al.
MOLECULAR CANCER (2021)
T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1
Yujiao He et al.
ELIFE (2021)
N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis
Naijun Hu et al.
BIOENGINEERED (2021)
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
Qiang Wang et al.
GUT (2020)
Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis
Jun Lu et al.
CANCER LETTERS (2020)
M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
Xueliang Zuo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Immunotherapy for Malignant Glioma: Current Status and Future Directions
Hongxiang Wang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang et al.
CANCER CELL (2020)
m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer
Bo Zhang et al.
MOLECULAR CANCER (2020)
Ran GTPase: A Key Player in Tumor Progression and Metastasis
Zied Boudhraa et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su et al.
CANCER CELL (2020)
HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
Zhi Yang et al.
Aging-US (2020)
m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling
Jian-Wei Xie et al.
MOLECULAR CANCER (2020)
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate Cancer
Markus Kreuz et al.
EUROPEAN UROLOGY (2020)
Epitranscriptomic regulation by m6A RNA methylation in brain development and diseases
Anil K. Chokkalla et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
N6-methyladenosine (m6A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint molecules
Pingfan Mo et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Screening and functional prediction of differentially expressed circular RNAs in human glioma of different grades
Xiuchao Geng et al.
Aging-US (2020)
Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas
Shengchao Xu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Central Nervous System Cancers Version 3.2020
Louis Burt Nabors et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
Dali Han et al.
NATURE (2019)
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
Junyu Long et al.
EBIOMEDICINE (2019)
m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
Seungwon Yang et al.
NATURE COMMUNICATIONS (2019)
RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail
Xinyao Lin et al.
NATURE COMMUNICATIONS (2019)
Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer
Cheng Zhang et al.
CANCER MEDICINE (2019)
Reading, writing and erasing mRNA methylation
Sara Zaccara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer
Yue Li et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Functions of N6-methyladenosine and its role in cancer
Liuer He et al.
MOLECULAR CANCER (2019)
Reading, writing and erasing mRNA methylation
Sara Zaccara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Knockdown of Ran GTPase expression inhibits the proliferation and migration of breast cancer cells
Chenyi Sheng et al.
MOLECULAR MEDICINE REPORTS (2018)
Epitranscriptomic m6A Regulation of Axon Regeneration in the Adult Mammalian Nervous System
Yi-Lan Weng et al.
NEURON (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
RNA m6A modification and its function in diseases
Jiyu Tong et al.
FRONTIERS OF MEDICINE (2018)
A dynamic N-6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
Fei Yan et al.
CELL RESEARCH (2018)
The role of yeast m6A methyltransferase in peroxisomal fatty acid oxidation
Pradeep Kumar Yadav et al.
CURRENT GENETICS (2018)
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
Elizabeth D. Thompson et al.
GUT (2017)
A seven-gene signature predicts overall survival of patients with colorectal cancer
Huarong Chen et al.
ONCOTARGET (2017)
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
Ly P. Vu et al.
NATURE MEDICINE (2017)
Progress in the treatment of advanced gastric cancer
Zheyu Song et al.
TUMOR BIOLOGY (2017)
Low expression of the GOPC is a poor prognostic marker in colorectal cancer
Nobuyoshi Ohara et al.
ONCOLOGY LETTERS (2017)
Screening Driving Transcription Factors in the Processing of Gastric Cancer
Guangzhong Xu et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Ran GTPase-Activating Protein 1 Is a Therapeutic Target in Diffuse Large B-Cell Lymphoma
Kung-Chao Chang et al.
PLOS ONE (2013)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
An essential role for Ran GTPase in epithelial ovarian cancer cell survival
Veronique Barres et al.
MOLECULAR CANCER (2010)
Chemotherapy for advanced gastric cancer
Anna Dorothea Wagner et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis
A. B. Dydensborg et al.
ONCOGENE (2009)
High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma
Hideyuki Abe et al.
INTERNATIONAL JOURNAL OF CANCER (2008)